Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing - Pokorna, Petra; Lakka Klement, Giannoula; Vasikova, Alzbeta; Kanderova, Veronika; Jezova, Marta; Noskova, Kristyna; Mudry, Peter; Kyr, Michal; Merta, Tomas; Bajciova, Viera; Krenova, Zdenka; Palova, Hana; et al. (JCO precision oncology, 2022)
Keywords: pyrazoly; aminopyridiny; makrocyklické laktamy; Neoplasm, Residual; laktamy; Humans; Pyrazoles; lidé; Lymphoma, Large-Cell, Anaplastic; Lactams; anaplastický velkobuněčný lymfom; Aminopyridines; reziduální nádor; Lactams, Macrocyclic